Pancreatic Cancer Research

ResearcherMorgan State UniversityActive in the last 2 years

Akram Pourshams

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7950-3983; OpenAlex author ID A5055449783. Sources: OpenAlex.

Their work

Papers
25 (first author 2, last author 15)
Trials
0
Grants
0
Labs led
1
Collaborators
27
Papers, trials and grants by year

2013: 1 paper · 2014: 2 papers · 2015: 2 papers · 2016: 2 papers · 2017: 2 papers · 2018: 2 papers · 2019: 2 papers · 2020: 2 papers · 2021: 5 papers · 2022: none · 2023: 1 paper · 2024: 3 papers · 2025: 1 paper

Papers 25

  1. Causal Exposures in Pancreatic Cancer Incidence: Insights From Mendelian Randomization Studies. Last author DOI 10.1002/jgh3.70105↗
  2. The association of dietary intake and plasma fatty acid panel in pancreatic cancer patients: Results from Golestan cohort study. Last author DOI 10.1177/02601060221114712↗
  3. Incidence and risk factors of pancreatic cancer during 15 years follow-up in the Golestan Cohort Study in Iran. Co-author DOI 10.1371/journal.pone.0300736↗
  4. Protective Effect of Dehydroepiandrosterone (DHEA) On Pancreatic Cancer Through C-Reactive Protein (CRP) Production Inhibition. Co-author DOI 10.61186/rbmb.13.2.174↗
  5. RNA-sequencing for transcriptional profiling of whole blood in early stage and metastatic pancreatic cancer patients. Last author DOI 10.1002/cbin.11924↗
  6. Dehydroepiandrosterone modulates oxidative DNA damage in pancreatic cancer: A case-control study. Co-author DOI 10.1002/jgh3.12604↗
  7. Circulating plasma fatty acids and risk of pancreatic cancer: Results from the Golestan Cohort Study. Last author DOI 10.1016/j.clnu.2020.09.002↗
  8. Dietary intake of fatty acids and risk of pancreatic cancer: Golestan cohort study. Last author DOI 10.1186/s12937-021-00723-3↗
  9. Diabetes Mellitus, Obesity, and Risk of Pancreatic Ductal Adenocarcinoma: a Large Case-Control Study from Iran. Last author DOI 10.34172/mejdd.2021.198↗
  10. Diagnostic Significance of Serum Fatty Acid Synthase in Patients with Pancreatic Cancer. Co-author DOI 10.34172/mejdd.2021.214↗
  11. Oral microbial community composition is associated with pancreatic cancer: A case-control study in Iran. Last author DOI 10.1002/cam4.2660↗
  12. Survival features, prognostic factors, and determinants of diagnosis and treatment among Iranian patients with pancreatic cancer, a prospective study. Last author DOI 10.1371/journal.pone.0243511↗
  13. The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic anal… Co-author DOI 10.1016/s2468-1253(19)30347-4↗
  14. An Increased Level of Aryl Hydrocarbon Receptor in Patients with Pancreatic Cancer. Co-author DOI 10.15171/mejdd.2018.126↗
  15. Opium Use and Risk of Pancreatic Cancer: A Prospective Cohort Study. Co-author DOI 10.1158/1055-9965.epi-17-0592↗
  16. Mutations in Known and Novel cancer Susceptibility Genes in Young Patients with Pancreatic Cancer. Last author PMID 29940740↗
  17. Menstrual and Reproductive Factors and Risk of Pancreatic Cancer in Women. Last author DOI 10.15171/mejdd.2017.65↗
  18. Pancreatic Cancer is Associated with Peripheral Leukocyte Oxidative DNA Damage First author DOI 10.22034/apjcp.2017.18.5.1349↗
  19. Opium use, cigarette smoking, and alcohol consumption in relation to pancreatic cancer. Last author DOI 10.1097/md.0000000000003922↗
  20. Major Dietary Protein Sources in Relation to Pancreatic Cancer: a Large Prospective Study. First author PMID 27041519↗
  21. Dietary food groups intake and cooking methods associations with pancreatic cancer: a case-control study. Last author DOI 10.1007/s12664-015-0573-4↗
  22. Direct Sequencing of Cyclooxygenase-2 (COX-2) Revealed an Intronic Variant rs201231411 in Iranian Patients with Pancreatic Cancer. Last author PMID 25628848↗
  23. Network of microRNAs-mRNAs interactions in pancreatic cancer. Co-author DOI 10.1155/2014/534821↗
  24. Validity and reliability of a questionnaire designed to assess risk factors of pancreatic cancer in Iran. Last author PMID 24527969↗
  25. Detection of TP53 R249 Mutation in Iranian Patients with Pancreatic Cancer. Last author DOI 10.1155/2013/738915↗

Closest collaborators

The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ashraf Mohamadkhani · 16 shared papers, 2013–2025 · strength 2.19
  2. Sahar Masoudi · 9 shared papers, 2017–2024 · strength 1.20
  3. Neda Ghamarzad Shishavan · 6 shared papers, 2017–2024 · strength 0.86
  4. Hamid Reza Fazli · 5 shared papers, 2013–2024 · strength 0.75
  5. Azita Hekmatdoost · 5 shared papers, 2015–2024 · strength 0.64
  6. Ramin Shakeri · 3 shared papers, 2016–2025 · strength 0.44
  7. Reza Malekzadeh · 5 shared papers, 2014–2018 · strength 0.28
  8. Mojtaba Jafarinia · 1 shared paper, 2024 · strength 0.28
  9. Paolo Boffetta · 4 shared papers, 2016–2018 · strength 0.26
  10. Zahra Momayez Sanat · 2 shared papers, 2017–2021 · strength 0.24
  11. Sara Mirzamohamadi · 1 shared paper, 2024 · strength 0.23
  12. Gholamreza Roshandel · 1 shared paper, 2024 · strength 0.23
  13. Maryam Zahedi · 1 shared paper, 2024 · strength 0.23
  14. Zahra Madjd · 1 shared paper, 2023 · strength 0.19
  15. Alberto D’Angelo · 1 shared paper, 2023 · strength 0.19
  16. Sima Kalantari · 1 shared paper, 2023 · strength 0.19
  17. Mojtaba Jafari Niya · 1 shared paper, 2021 · strength 0.17
  18. Paul Brennan · 2 shared papers, 2018–2020 · strength 0.16
  19. Elnaz Naderi · 3 shared papers, 2013–2015 · strength 0.16
  20. Zeinab Ghorbani · 2 shared papers, 2015–2016 · strength 0.13
  21. Solmaz Farrokhzad · 2 shared papers, 2014–2015 · strength 0.11
  22. Mahdi Sheikh · 1 shared paper, 2020 · strength 0.10
  23. Saman Nikeghbalian · 1 shared paper, 2020 · strength 0.10
  24. Emily Vogtmann · 1 shared paper, 2020 · strength 0.09
  25. Sarah Mirzaie · 1 shared paper, 2018 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.